SynthesisBMC public health2025
Assessing implementation outcomes from studies addressing medication adherence for hypertension management in Sub-Saharan Africa: a systematic review.
Synthesis in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevalence of hypertension in Sub-Saharan Africa is as high as 48%, with medication adherence as low as 34.1%. Prioritizing hypertension management through medication adherence is the most effective means to improve outcomes. We report a systematic review of evidence-based interventions for medication adherence that, when effectively implemented, can improve hypertension management in Sub-Saharan Africa.
methodsWe searched the Web of Science, CINAHL, EMBASE, Global Index Medicus, PubMed/Medline, and APA PsycINFO databases. The search included articles from inception to October 26, 2022, which was later updated on October 1, 2023. Only studies (randomized controlled trials (RCTs), Non- RCTs, and Mixed Methods studies) conducted in Sub-Saharan Africa that reported on interventions addressing hypertension management and medication adherence, and reported on implementation outcomes, were included. The studies were assessed and categorized according to the standard of the framework developed by Proctor E, et al. and the scalability element developed by Gyamfi J, et al. The implementation outcomes assessed included acceptability, adoption (uptake), appropriateness, cost, feasibility fidelity, penetration, scalability, and sustainability. An Assessment of quality and risk of bias for each study was performed by two reviewers using the Cochrane risk-of-bias tool (RCTs), the JBI Critical Appraisal Tool for Quasi-Experimental Studies (Non-RCTs) and the Mixed Methods Appraisal Tool for all other study types.
resultsA total of 3,782 articles were identified through database and citation searches. After removing duplicates and article screening, 14 articles met all of the study's inclusion criteria and were extracted. The studies included were implemented in Nigeria, Uganda, Ghana, and South Africa. Pharmacist-led (n = 4), Nurse-led (n = 2), Mobile (n = 3), Group (n = 2), and Health education (n = 3) interventions were included. All 14 interventions demonstrated improvements in medication adherence. Among studies reporting both pre and post intervention data, improvements ranged from 1.3 to 88%. The implementation outcomes measured helped to clarify how practitioners can implement these evidence-based interventions more effectively. The implementation outcomes of appropriateness, feasibility, acceptability, and cost were identified in more than half of the studies.
conclusionsThe implementation of evidence-based hypertension interventions can improve medication adherence. However, stakeholder input and further research is needed to assess the practicality of implementing evidence-based intervention in Sub-Saharan Africa. PROTOCOL REGISTRATION: This review was registered with PROSPERO (CRD42023360315). https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42023360315 .
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.